Attorneys for the state are asking a federal judge to dismiss a lawsuit filed by manufacturers of generic pharmaceuticals attacking the constitutionality of Maryland’s new price gouging law, set to go into effect in October. The hearing, scheduled for 5 ...Read More »
Maryland’s first-in-the-nation law seeking to eliminate price gouging by makers of generic pharmaceuticals has been challenged by the manufacturers, who claim the law is discriminatory and an unconstitutional overreach. House Bill 631, which passed both chambers of the General Assembly ...Read More »
The drug Naloxone, often sold under the brand name Narcan, has become a critical tool in the fight against the opioid epidemic. But since the drug’s ability to counter overdoses became popularized in 2014, its price has more than doubled. ...
Tagged with: aarp Allen Goldberg Association for Accessible Medicines Attorney General Brian E. Frosh Danya Qato Dr. Leana Wen drug price gouging generics Hank Greenberg jeremy greene Johns Hopkins University School of Medicine Maryland Citizens' Health Initiative naloxone prescriptions School of Pharmacy TJ Garrigan Vincent DeMarcoRead More »